Skip to main content

NovoCure Ltd insider trading

NVCRNASDAQ
$14.94-0.98 (-6.16%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (+6.3%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Unlock quarterly net flow

Key players

    AI Activity Analysis

    Premium
    Coming soonAI reads of insider activity will appear here for Premium accounts.

    Insider activity

    Fromto
    CompanyInsider / roleActionΔOwnAvg priceAmount
    NVCRFrank X. LeonardChief Executive OfficerOpen market sell$615K-6.9%$17.93$615KJun 4, 2026Jun 5, 2026
    NVCRKristin StaffordDirectorOpen market sell$46.4K-20.6%$15.77$46.4KJun 2, 2026Jun 3, 2026
    NVCRAllyson J. OceanDirectorOpen market sell$46.4K-20.6%$15.77$46.4KJun 2, 2026Jun 3, 2026
    NVCRTimothy J. ScannellDirectorOpen market sell$46.4K-17.1%$15.77$46.4KJun 2, 2026Jun 3, 2026
    NVCRW. Anthony VernonDirectorOpen market sell$46.4K-1.5%$15.77$46.4KJun 2, 2026Jun 3, 2026
    NVCRDavid HungDirectorOpen market sell$46.4K-12.6%$15.77$46.4KJun 2, 2026Jun 3, 2026
    NVCRGabriel LeungDirectorOpen market sell$46.4K-3.2%$15.77$46.4KJun 2, 2026Jun 3, 2026
    NVCRJeryl L. HillemanDirectorOpen market sell$46.4K-17.5%$15.77$46.4KJun 2, 2026Jun 3, 2026
    NVCRMukund ParavasthuChief Operating OfficerOpen market sell$595K-37.3%$13.77$595KMar 5, 2026Mar 5, 2026
    NVCRChristoph BrackmannChief Financial OfficerOpen market sell$85.3K-3.4%$13.31$85.3KMar 4, 2026Mar 5, 2026
    NVCRMukund ParavasthuChief Operating OfficerOpen market sell$71.6K-4.4%$13.31$71.6KMar 4, 2026Mar 5, 2026
    NVCRNicolas LeupinFormer Chief Medical OfficerOpen market sell$14.6K-1.1%$13.31$14.6KMar 4, 2026Mar 5, 2026
    NVCRMichal Nath PuriChief Human Resources OfficerOpen market sell$14.6K-0.5%$13.31$14.6KMar 4, 2026Mar 5, 2026
    NVCRFrank X. LeonardChief Executive OfficerOpen market sell$74.6K-1.1%$13.31$74.6KMar 4, 2026Mar 5, 2026
    NVCRUri WeinbergChf Medical and Innovation OfrOpen market sell$85.3K-2.3%$13.31$85.3KMar 4, 2026Mar 5, 2026
    NVCRWilliam F. DoyleExecutive ChairmanOpen market sell$286K-6.1%$13.43$286KMar 3, 2026Mar 5, 2026
    NVCRWilliam F. DoyleExecutive ChairmanOpen market sell$647K-12.6%$12.79$647KMar 3, 2026Mar 5, 2026
    NVCRMukund ParavasthuChief Operating OfficerOpen market sell$5.5K-0.5%$13.49$5.5KMar 2, 2026Mar 3, 2026
    NVCRFrank X. LeonardChief Executive OfficerOpen market sell$97.6K-2.0%$13.49$97.6KMar 2, 2026Mar 3, 2026
    NVCRUri WeinbergChf Medical and Innovation OfrOpen market sell$43.6K-1.4%$13.33$43.6KMar 2, 2026Mar 3, 2026
    NVCRMukund ParavasthuChief Operating OfficerOpen market sell$21.2K-2.0%$13.66$21.2KFeb 27, 2026Mar 3, 2026
    NVCRNicolas LeupinFormer Chief Medical OfficerOpen market sell$14.1K-1.0%$13.66$14.1KFeb 27, 2026Mar 3, 2026
    NVCRMichal Nath PuriChief Human Resources OfficerOpen market sell$19.7K-0.9%$13.66$19.7KFeb 27, 2026Mar 3, 2026
    NVCRFrank X. LeonardChief Executive OfficerOpen market sell$133K-2.8%$13.66$133KFeb 27, 2026Mar 3, 2026
    NVCRUri WeinbergChf Medical and Innovation OfrOpen market sell$103K-3.4%$13.84$103KFeb 27, 2026Mar 3, 2026
    End of history · 25 transactions

    Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.